Prosecution Insights
Last updated: November 04, 2026
Application No. 18/226,408

Method and Apparatus for Detecting Conditions from Physiology Data

Non-Final OA §101
Filed
Jul 26, 2023
Priority
Jul 26, 2022 — provisional 63/392,218
Examiner
COVINGTON, AMANDA R
Art Unit
3686
Tech Center
3600 — Transportation & Electronic Commerce
Assignee
Prolaio Inc.
OA Round
1 (Non-Final)
22%
Grant Probability
At Risk
1-2
OA Rounds
4m
Est. Remaining
50%
With Interview

Examiner Intelligence

Grants only 22% of cases
22%
Career Allowance Rate
32 granted / 149 resolved
-30.5% vs TC avg
Strong +28% interview lift
Without
With
+28.1%
Interview Lift
resolved cases with interview
Typical timeline
3y 7m
Avg Prosecution
37 currently pending
Career history
190
Total Applications
across all art units

Statute-Specific Performance

§101
40.8%
+0.8% vs TC avg
§103
35.6%
-4.4% vs TC avg
§102
6.7%
-33.3% vs TC avg
§112
14.7%
-25.3% vs TC avg
Black line = Tech Center average estimate • Based on career data from 149 resolved cases

Office Action

§101
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Rejections - 35 USC § 101 35 U.S.C. 101 reads as follows: Whoever invents or discovers any new and useful process, machine, manufacture, or composition of matter, or any new and useful improvement thereof, may obtain a patent therefor, subject to the conditions and requirements of this title. Claims 1-16 are rejected under 35 U.S.C. 101 because the claimed invention is directed to a judicial exception (i.e., an abstract idea) without significantly more. Step 1 of the Alice/Mayo Test Claims 1-8 are drawn to a method, which is within the four statutory categories (i.e. process). Claims 9-16 are drawn to a system, which is within the four statutory categories (i.e. apparatus). Step 2A of the Alice/Mayo Test - Prong One The independent claims recite an abstract idea. For example, claim 1 (and substantially similar with independent claim 9) recites: A method for monitoring a patient for effects of a pharmacological therapy comprising the steps of: collecting physiology data from at least one wearable sensor worn by the patient during a pre-treatment interval; creating an individualized estimator model based on the patient's pre-treatment collected physiology data, the model capable of estimating physiological variables responsive to receiving new physiology data from the at least one wearable sensor worn by the patient; collecting additional physiology data from the at least one wearable sensor worn by the patient during a post-treatment interval; generating estimates of the post-treatment physiology data using the individualized estimator model; comparing post-treatment physiology data to the estimates thereof and determining when a pre-defined effect pattern is present based at least in part on the comparison; and when the predefined effect pattern is present, determining and performing an action, the action being one or more of: triggering an electronic questionnaire to be prompted to the patient; providing instructions to the patient to take a measurement; providing instructions to the patient to contact the patient's clinician; triggering a ticket in a call center system to queue a call to the patient; creating a prompt in an app on the patient's phone to contact a clinician; providing instructions to the patient related to triaging the effects; transmitting a control signal to control medical equipment associated with treating the patient; transmitting instructions to a vaccine manufacture to alter a composition and/or dosage of a vaccine. These underlined elements recite an abstract idea that can be categorized, under its broadest reasonable interpretation, to cover the management of personal behavior or interactions (i.e., following rules or instructions), but for the recitation of generic computer components. For example, but for the wearable sensor, estimator model, electronic questionnaire, call center system, app on a phone, control medical equipment, control circuit, the limitations in the context of this claim encompass following rules or instructions to gather patient data for pattern analysis in order to determine triggering actions to be performed by or related to the patient. If a claim limitation, under its broadest reasonable interpretation, covers management of personal behavior or interactions but for the recitation of generic computer components, then the limitations fall within the “Certain Methods of Organizing Human Activity” grouping of abstract ideas. See MPEP § 2106.04(a). Dependent claims recite additional subject matter which further narrows or defines the abstract idea embodied in the claims (such as claims 2-8 and 10-16 reciting particular aspects of the abstract idea). Step 2A of the Alice/Mayo Test - Prong Two For example, claim 1 (and substantially similar with independent claim 9) recites: A method for monitoring a patient for effects of a pharmacological therapy comprising the steps of: collecting physiology data from at least one wearable sensor worn by the patient (merely invokes use of computer and other machinery as a tool as noted below, see MPEP 2106.05(f)) during a pre-treatment interval; creating an individualized estimator model based on the patient's pre-treatment collected physiology data, the model capable of estimating physiological variables responsive to receiving new physiology data from the at least one wearable sensor worn by the patient; (merely invokes use of computer and other machinery as a tool as noted below, see MPEP 2106.05(f)) collecting additional physiology data from the at least one wearable sensor worn by the patient (merely invokes use of computer and other machinery as a tool as noted below, see MPEP 2106.05(f)) during a post-treatment interval; generating estimates of the post-treatment physiology data using the individualized estimator model; (merely invokes use of computer and other machinery as a tool as noted below, see MPEP 2106.05(f)) comparing post-treatment physiology data to the estimates thereof and determining when a pre-defined effect pattern is present based at least in part on the comparison; and when the predefined effect pattern is present, determining and performing an action, the action being one or more of: triggering an electronic (merely invokes use of computer and other machinery as a tool as noted below, see MPEP 2106.05(f)) questionnaire to be prompted to the patient; providing instructions to the patient to take a measurement; providing instructions to the patient to contact the patient's clinician; triggering a ticket in a call center system (merely invokes use of computer and other machinery as a tool as noted below, see MPEP 2106.05(f)) to queue a call to the patient; creating a prompt in an app on the patient's phone (merely invokes use of computer and other machinery as a tool as noted below, see MPEP 2106.05(f)) to contact a clinician; providing instructions to the patient related to triaging the effects; transmitting a control signal to control medical equipment (merely invokes use of computer and other machinery as a tool as noted below, see MPEP 2106.05(f)) associated with treating the patient; transmitting instructions to a vaccine manufacture to alter a composition and/or dosage of a vaccine. The judicial exception is not integrated into a practical application. In particular, the additional elements do not integrate the abstract idea into a practical application, other than the abstract idea per se, because the additional elements amount to no more than limitations, which: amount to mere instructions to apply an exception (such as recitations of the wearable sensor, estimator model, electronic questionnaire, call center system, app on a phone, control medical equipment, control circuit, thereby invoking computers as a tool to perform the abstract idea, see applicant’s specification [0020], [0027]-[0028], [0097]-[0110], see MPEP 2106.05(f)) Dependent claims recite additional subject matter which amount to limitations consistent with the additional elements in the independent claims (such as claims 2-7, 10-15 recites additional elements that further the abstract idea; claims 5, 8, 13, and 16 recite additional limitations which amount to invoking computers as a tool to perform the abstract idea, and claims 2-8 and 10-16 additional limitations which generally link the abstract idea to a particular technological environment or field of use). Looking at the limitations as an ordered combination adds nothing that is not already present when looking at the elements taken individually. There is no indication that the combination of elements improves the functioning of a computer or improves any other technology. Their collective functions merely provide conventional computer implementation and do not impose a meaningful limit to integrate the abstract idea into a practical application. Step 2B of the Alice/Mayo Test for Claims The claims do not include additional elements that are sufficient to amount to significantly more than the judicial exception. As discussed above with respect to discussion of integration of the abstract idea into a practical application, the additional elements amount to no more than mere instructions to apply an exception. Additionally, the additional elements, other than the abstract idea per se, amount to no more than elements which: amount to elements that have been recognized as well-understood, routine, and conventional activity in particular fields (such as using the wearable sensor, estimator model, electronic questionnaire, call center system, app on a phone, control medical equipment, control circuit, e.g., Applicant’s spec describes the computer system with it being well-understood, routine, and conventional because it describes in a manner that the additional elements are sufficiently well-known that the specification does not need to describe the particulars of such elements to satisfy 112a. (See Applicant’s Spec. [0020], [0027]-[0028], [0097]-[0110]); using a the wearable sensor, estimator model, electronic questionnaire, call center system, app on a phone, control medical equipment, control circuit, e.g., merely adding a generic computer, generic computer components, or a programmed computer to perform generic computer functions, Alice Corp. Pty. Ltd. v. CLS Bank Int’l, 134 S. Ct. 2347, 2358-59, 110 USPQ2d 1976, 1983-84 (2014). Dependent claims recite additional subject matter which, as discussed above with respect to integration of the abstract idea into a practical application, amount to invoking computers as a tool to perform the abstract idea, and are generally linking the abstract idea to a particular field of environment. Looking at the limitations as an ordered combination adds nothing that is not already present when looking at the elements taken individually. There is no indication that the combination of elements improves the functioning of a computer or improves any other technology. Their collective functions merely provide conventional computer implementation. Therefore, the claims are not patent eligible, and are rejected under 35 U.S.C. § 101. Subject Matter Free of Prior Art Claims 1-16 are free of prior art over Rogers et al. (WO 2019/161277) and Al-Ali et al. (US 2021/0330224). The prior art references, or reasonable combination thereof, could not be found to disclose, or suggest all of the limitations found in the independent claims. The closest prior art is Rogers et al. (WO 2019/161277), discloses a method for monitoring a patient for effects of a pharmacological therapy where medical wearable sensors are used to monitor heart rates and a threshold triggers corrective, stimulatory, biofeedback, or reinforcing signal back to the subject. Al-Ali et al. (US 2021/0330224) teaches a wireless patient monitoring device including one or more sensors configured to obtain physiological information, the one or more sensors are connected to a wireless monitor configured to receive the sensor data and to wirelessly transmit sensor data or physiological parameters reflective of the sensor data lo a bedside monitor. The references taken solely, or in combination, fail to provide the required limitations, and modification of any complementary combination of the references of record would be impermissible hindsight and not provide any advantages over their present application. The dependent claims are also free of prior art due to their corresponding dependency of the independent claims. Conclusion The prior art made of record and not relied upon is considered pertinent to applicant's disclosure. Johnson et al. (US 2018/0268507) is considered pertinent for teaching using wearable sensors to monitor physiological parameters for specific times, while estimating recuperative benefits and determining when it exceeds a threshold based on designated criteria. Any inquiry concerning this communication or earlier communications from the examiner should be directed to AMANDA R COVINGTON whose telephone number is (303)297-4604. The examiner can normally be reached Monday - Friday, 10 - 5 MT. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Jason B. Dunham can be reached at (571) 272-8109. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /AMANDA R. COVINGTON/Examiner, Art Unit 3686 /JASON B DUNHAM/Supervisory Patent Examiner, Art Unit 3686
Read full office action

Prosecution Timeline

Jul 26, 2023
Application Filed
Oct 20, 2026
Non-Final Rejection mailed — §101 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12658290
TEAM-BASED TELE-DIAGNOSTICS BLOCKCHAIN-ENABLED SYSTEM
2y 10m to grant Granted Jun 16, 2026
Patent 12632773
INSULIN THERAPY DETERMINATION
5y 3m to grant Granted May 19, 2026
Patent 12620471
APPLICATION TONALITY ADJUSTMENT MODEL
2y 7m to grant Granted May 05, 2026
Patent 12614618
INTERACTIVE AGENT INTERFACE AND OPTIMIZED HEALTH PLAN RANKING
3y 5m to grant Granted Apr 28, 2026
Patent 12417834
GENETICALLY PERSONALIZED INTRAVENOUS AND INTRAMUSCULAR NUTRITION THERAPY DESIGN SYSTEMS AND METHODS
3y 1m to grant Granted Sep 16, 2025
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
22%
Grant Probability
50%
With Interview (+28.1%)
3y 7m (~4m remaining)
Median Time to Grant
Low
PTA Risk
Based on 149 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month